228 related articles for article (PubMed ID: 6090618)
21. Clinical significance of 99mTc-N-pyridoxyl-5-methyltryptophan (99mTc-PMT) in the diagnosis of intrahepatic masses.
Oyamada H; Yamazaki S; Makuuchi M; Hasegawa H
Radioisotopes; 1989 May; 38(5):244-51. PubMed ID: 2546192
[TBL] [Abstract][Full Text] [Related]
22. Hepatobiliary imaging of functional and morphological changes following hepatic arterial embolization in hepatocellular carcinoma.
Tai DI; Chen HY; Wang PW; Lee CH; Lee TY; Chen WJ; Chen JJ; Chang Chien CS
J Nucl Med; 1995 Sep; 36(9):1590-4. PubMed ID: 7658215
[TBL] [Abstract][Full Text] [Related]
23. Concentration of 99mTc-Sn-N-pyridoxyl-5-methyltryptophan, a biliary agent, in distant metastases of hepatomas.
Hasegawa Y; Nakano S; Ibuka K; Hashizume T; Sasaki Y; Imaoka S; Ishiguro S; Tanaka S; Kasugai H; Okano Y
Eur J Nucl Med; 1985; 10(5-6):255-8. PubMed ID: 2985390
[TBL] [Abstract][Full Text] [Related]
24. [The utility of quantitative 99mTc-GSA liver scintigraphy in the evaluation of hepatic functional reserve: comparison with 99mTc-PMT and 99mTc-Sn colloid].
Shuke N; Aburano T; Nakajima K; Yokoyama K; Sun BF; Matsuda H; Muramori A; Michigishi T; Tonami N; Hisada K
Kaku Igaku; 1992 May; 29(5):573-84. PubMed ID: 1434071
[TBL] [Abstract][Full Text] [Related]
25. Quest for the perfect hepatobiliary radiopharmaceutical.
Fritzberg AR; Klingensmith WC
J Nucl Med; 1982 Jun; 23(6):543-6. PubMed ID: 6896213
[No Abstract] [Full Text] [Related]
26. A new synthetic method for 99mTc labeled N-pyridoxyl-5-methyltryptophan as a hepatoma imaging agent.
Zhou YG; Zhu T; Zhao HY; Wu ZM; Shi QX; Liang FH
Int J Rad Appl Instrum B; 1987; 14(5):467-73. PubMed ID: 2822632
[TBL] [Abstract][Full Text] [Related]
27. [Diagnosis of acute cholecystitis using hepatobiliary scintigraphy with 99mTc-PMT].
Takada T; Yasuda H; Uchiyama K; Hasegawa H; Shikata J; Kuniyasu Y; Higashi S
Nihon Igaku Hoshasen Gakkai Zasshi; 1985 Jul; 45(7):1032-8. PubMed ID: 4080522
[No Abstract] [Full Text] [Related]
28. [Two cases of skeletal metastasis of hepatocellular carcinoma demonstrating an abnormal accumulation of Tc-99m PMT].
Tada A; Tatsuno I; Takanaka T; Yasuda T; Wakabayashi T; Kinoshita M
Rinsho Hoshasen; 1987 Jan; 32(1):139-42. PubMed ID: 3033353
[No Abstract] [Full Text] [Related]
29. Extraosseous metastases of hepatocellular carcinoma detection and therapeutic assessment with Tc-99m PMT SPECT.
Hayase N; Fukumoto M; Yoshida D; Kariya S; Akagi N; Kurohara A; Hisa N; Yoshida S
Clin Nucl Med; 1999 May; 24(5):326-9. PubMed ID: 10232470
[TBL] [Abstract][Full Text] [Related]
30. Metastasis of hepatocellular carcinoma to the colon demonstrated by Tc-99m PMT scintigraphy.
Fukui H; Kashiwagi T; Shirai Y; Matsuda Y; Kawata S; Nishimura T; Kozuka T
Clin Nucl Med; 1993 Jun; 18(6):512-5. PubMed ID: 8391407
[TBL] [Abstract][Full Text] [Related]
31. TC-99m(Sn)-N-pyridoxylaminates: a new series of hepatobiliary imaging agents.
Kato-Azuma M
J Nucl Med; 1982 Jun; 23(6):517-24. PubMed ID: 7077403
[TBL] [Abstract][Full Text] [Related]
32. [Usefulness of 99mTc-PMT cholescintigraphy in diagnosis a case of bone metastasis in hepatocellular carcinoma].
Inoue A; Imaeda T; Yanagawa S; Doi T
Rinsho Hoshasen; 1989 Aug; 34(8):901-2. PubMed ID: 2555595
[No Abstract] [Full Text] [Related]
33. Small hepatocellular carcinoma visualized with technetium-99m(Sn)-N-pyridoxyl-5-methyltryptophan.
Narabayashi I; Hamada T; Aoki O; Suematsu T
Ann Nucl Med; 1987 Sep; 1(1):39-42. PubMed ID: 2856317
[TBL] [Abstract][Full Text] [Related]
34. [Hepatobiliary functions in primary biliary cirrhosis--assessment with 99mTc-PMT hepatobiliary scintigraphy].
Imai Y
Kaku Igaku; 1994 Mar; 31(3):249-56. PubMed ID: 8176863
[TBL] [Abstract][Full Text] [Related]
35. [Hepatobiliary scintigraphy and liver function test with 99mTc-N-pyridoxyl-5-methyltryptophan (99mTc-PMT)].
Sugimura K; Narabayashi I; Nabeshima K; Ishido N; Hashimoto K; Yamasaki K; Hamada T; Sugimura C; Suematsu T; Inoue Y
Nihon Igaku Hoshasen Gakkai Zasshi; 1983 Oct; 43(10):1205-13. PubMed ID: 6672750
[No Abstract] [Full Text] [Related]
36. [Quantitative analysis by digital computer with Tc-99m PMT hepatogram in diffuse parenchymal liver diseases].
Narabayashi I; Ishido N; Sugimura K; Nabeshima K; Matsuo M; Kimura S; Kajita A
Kaku Igaku; 1984 Jan; 21(1):41-4. PubMed ID: 6737788
[No Abstract] [Full Text] [Related]
37. Clinical evaluation on hepatobiliary scintigraphy with 99mTc(Sn)-N-pyridoxyl-5-methyltryptophan.
Yamashita M; Watanabe A; Miyazaki T; Nakajima E; Okuno T
Radioisotopes; 1982 Dec; 31(12):657-9. PubMed ID: 7170355
[No Abstract] [Full Text] [Related]
38. Discordant hepatic uptake of Tc-99m NGA and Tc-99m PMT in a patient with hepatoma.
Aburano T; Shuke N; Yokoyama K; Tonami N; Hisada K; Tanei M; Terada M; Unoura M; Kobayashi K
Clin Nucl Med; 1992 Oct; 17(10):793-6. PubMed ID: 1330392
[TBL] [Abstract][Full Text] [Related]
39. [Radionuclear estimation with 99mTc-N-pyridoxyl-5-methyl-tryptophan (PMT) scintigraphy of recurrent hepatocellular carcinoma after non-surgical treatment].
Matsumoto H; Matsuura M; Sakurai H; Nakajima N; Ito K
Nihon Igaku Hoshasen Gakkai Zasshi; 1997 Oct; 57(12):805-11. PubMed ID: 9394570
[TBL] [Abstract][Full Text] [Related]
40. [Basic and clinical evaluation of hepatobiliary function by 99mTc-pyridoxyl-5-methyl-tryptophan].
Morimoto Y; Tochio H; Yamada A; Hamasaki T; Saiki Y; Bito S; Ito H; Ikekubo K; Senda M; Kudo M
Kaku Igaku; 1983 Nov; 20(9):1361-9. PubMed ID: 6676522
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
